MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 76 filers reported holding MARKER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $725 | -27.5% | 2,727 | +0.4% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 2,717 | -0.3% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 2,726 | +1.3% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 2,691 | +0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -71.4% | 2,690 | -27.1% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 3,690 | -0.9% | 0.00% | – |
| Q2 2021 | $10,000 | -56.5% | 3,724 | -65.4% | 0.00% | – |
| Q1 2021 | $23,000 | -69.3% | 10,777 | -79.2% | 0.00% | – |
| Q4 2020 | $75,000 | -42.3% | 51,913 | -40.1% | 0.00% | – |
| Q3 2020 | $130,000 | -30.9% | 86,677 | -4.4% | 0.00% | – |
| Q2 2020 | $188,000 | +248.1% | 90,619 | +219.0% | 0.00% | – |
| Q1 2020 | $54,000 | -40.7% | 28,404 | -9.9% | 0.00% | – |
| Q4 2019 | $91,000 | -63.3% | 31,535 | -35.1% | 0.00% | – |
| Q3 2019 | $248,000 | -0.4% | 48,593 | +54.6% | 0.00% | – |
| Q2 2019 | $249,000 | – | 31,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |